Skip to main content
. 2018 May 2;37:96. doi: 10.1186/s13046-018-0766-7

Fig. 4.

Fig. 4

Survival analyses. a Disease-free-survival (DFS) curves for patients with nTWIST1+ versus nTWIST1- expression (p < 0.001). b DFS curves for patients with simultaneously nTWIST1-/mNHERF1+ expression respect to patients with nTWIST1+/mNHERF1- expression (p < 0.001). c DFS curves for patients with simultaneously nTWIST1-/mNHERF1- expression respect to patients with nTWIST1+/mNHERF1+ expression (p = 0.510). d DFS curves for patients with simultaneously nTWIST1-/cNHERF1- expression respect to patients with nTWIST1+/cNHERF1+ expression (p = 0.004). e DFS curves for patients with simultaneously nTWIST1-/cNHERF1+ expression respect to patients with nTWIST1+/cNHERF1- expression (p = 0.037). f DFS curves for patients with simultaneously cVEGF-/cNHERF1- expression respect to patients with cVEGF+/cNHERF1+ expression (p = 0.430). g DFS curves for patients with simultaneously cVEGFR1-/cNHERF1- expression respect to patients with cVEGFR1+/cNHERF1+ expression (p = 0.180). h DFS curves for patients with simultaneously nHIF-1α-/cNHERF1+ expression respect to patients with nHIF-1α+/cNHERF1- expression (p = 0.950)